About This Calculator

The Humira (adalimumab) Dosing Calculator is a clinical support tool designed to determine the appropriate induction and maintenance dosing regimens based on FDA-approved indications. It processes patient-specific parameters like age, weight, and clinical indication to provide a recommended dosing schedule. This guide explains the calculator's inputs, outputs, and provides supplementary clinical information.

Outputs Explained

Upon successful calculation, the tool provides the following information:

• Induction Dose: The initial, higher dose required to quickly achieve therapeutic levels of the medication. This is common for indications like Crohn's Disease, Ulcerative Colitis, and Hidradenitis Suppurativa.
• Maintenance Dose: The ongoing, regular dose used to maintain therapeutic effects after the induction phase.
• Dosing Schedule: The frequency of administration, such as weekly, every other week, or every four weeks.
• Administration Route: Clarifies that all doses are for subcutaneous (SC) injection.
• Clinical Notes: Provides context-specific information, such as the option for a split induction dose or dose escalation for certain conditions.

How to Use the Calculator

To calculate a dosing regimen, enter the following patient data into the tool:

1. Indication: Select the specific medical condition for which Humira is being prescribed (e.g., Rheumatoid Arthritis, Plaque Psoriasis).
2. Patient Age: Enter the patient's age in years. This is crucial as dosing differs between adult and pediatric populations.
3. Patient Weight: Provide the patient's body weight. You can toggle between kilograms (kg) and pounds (lbs). The tool uses weight to calculate doses for certain pediatric indications like JIA and Crohn's Disease.
4. Concomitant Methotrexate (MTX): For Rheumatoid Arthritis (RA) only, specify if the patient is also taking methotrexate, as this can influence dosing recommendations.

Dosing Overview

Humira dosing is highly specific to the indication and patient population (adult vs. pediatric). Many conditions, particularly in rheumatology (RA, PsA, AS), use a standard maintenance dose of 40 mg every other week. In contrast, inflammatory bowel diseases (CD, UC) and hidradenitis suppurativa (HS) require a higher induction dose (e.g., 160 mg on Day 1, 80 mg on Day 15) followed by a maintenance regimen. Pediatric dosing is often weight-based, with specific tiers for conditions like Juvenile Idiopathic Arthritis.

Switching To or From Humira

Switching a patient to Humira from another biologic, or from Humira to another agent, requires careful clinical consideration. The timing of the switch depends on the pharmacokinetic properties of both drugs involved. There is no universal protocol, and decisions must be individualized by the prescribing clinician to minimize the risk of disease flares or adverse events. The decision should be guided by clinical practice guidelines and the specific patient's disease activity and history.

Missed Dose Instructions

If a patient misses a dose of Humira, they should be instructed to take the missed dose as soon as they remember. Afterward, they should resume their original schedule from the date of the most recent injection. For example, if they take a missed dose on a Tuesday for an "every other week" schedule, their next dose should be two weeks from that Tuesday. Patients should not take two doses at the same time to make up for a missed one.

Safety Alerts

Frequently Asked Questions

1. What is the standard adult dose for Rheumatoid Arthritis?

The standard maintenance dose for adults with RA is 40 mg administered subcutaneously every other week. If the patient is not on concomitant methotrexate, the dose may be increased to 40 mg weekly in cases of inadequate response.

2. How is the 160 mg induction dose administered for Crohn's Disease?

The 160 mg induction dose can be given in two ways: either as four 40 mg injections in a single day, or as two 40 mg injections per day for two consecutive days.

3. Is Humira dosing weight-based for adults?

For most adult indications, such as RA, PsA, and AS, the dose is a fixed amount (e.g., 40 mg) and not based on weight. However, for pediatric patients, dosing for JIA, CD, and UC is often weight-dependent.

4. At what age can children start Humira for Crohn's Disease?

Humira is approved for the treatment of Crohn's Disease in pediatric patients aged 6 years and older.

5. What is the initial "loading" dose for Plaque Psoriasis?

For adult Plaque Psoriasis, the regimen starts with an initial dose of 80 mg, followed by the maintenance dose of 40 mg every other week starting one week after the initial dose.

6. Does the dose for Ulcerative Colitis differ between adults and children?

Yes. While the induction dose structure is similar, the maintenance dose for pediatric patients weighing 20 kg to <40 kg can be 20 mg every other week or 40 mg every 4 weeks, which differs from the standard adult maintenance dose of 40 mg every other week.

7. What is the recommended dose for Juvenile Idiopathic Arthritis (JIA) in a child weighing 20 kg?

For a child with JIA weighing between 15 kg and <30 kg, the recommended dose is 20 mg every other week.

8. Are there any pre-screening tests required before starting Humira?

Yes, all patients should be screened for latent tuberculosis (TB) and Hepatitis B virus (HBV) infection prior to initiating therapy. A review of vaccination status is also recommended.

References

1. HUMIRA (adalimumab) Prescribing Information. U.S. Food and Drug Administration. Revised: 06/2023. Available at: FDA.gov.
2. AbbVie Inc. HUMIRA® (adalimumab) Dosing and Administration. Official Manufacturer HCP Site. Accessed August 2024. Available at: humirahcp.com.
3. Humira (adalimumab) Summary of Product Characteristics. European Medicines Agency. Accessed August 2024. Available at: ema.europa.eu.
4. Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(1):1-26. doi:10.1002/art.39480.